Baxter Recalls Clinimix E Due to Sterility Assurance Concerns
Baxter Healthcare is recalling 7,444 containers of Clinimix E 5/20 due to a lack of assurance of sterility and increased leak complaints.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a 'Severe' rating under the rubric for significant injury or property damage risks, specifically involving a lack of sterility assurance in an intravenous product.
Plain-English summary
Baxter Healthcare Corporation is recalling 7,444 containers of Clinimix E 5/20 sulfite-free Injection, 2000 mL in Dual Chamber Container. The product is a prescription-only intravenous solution containing amino acids, electrolytes, and dextrose. The recall is being conducted due to a lack of assurance of sterility and an increase in complaints regarding leaks.
The affected product is identified by Product code 2B7722, Lot number P306365, and an expiration date of 8/31/2015. The distribution pattern for this recall includes nationwide distribution in the United States and Singapore.
Consumers and healthcare providers should check their inventory for the specific lot number and expiration date listed above. If the product is found, it should be removed from use and returned to the distributor or manufacturer according to standard recall procedures.
The recalled product
- Product
- CLINIMIX E (LEUCINE, PHENYLALANINE, LYSINE, METHIONINE, ISOLEUCINE, VALINE, HISTIDINE, THREONINE, TRYPTOPHAN, ALANINE, GLYCINE, ARGININE, PROLINE, SERINE, TYROSINE, DIBASIC POTASSIUM PHOSPHATE, MAGNESIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE, DEXTROSE)
- Brand
- CLINIMIX E
- Manufacturer
- Baxter Healthcare Corp
- Category
- Drug — Intravenous Solution
- Affected units
- 7,444
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Product code: 2B7722
- Lot#: P306365
- exp date: 8/31/2015
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Baxter Healthcare Corp under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same brand · CLINIMIX E
- CriticalBaxter Recalls Clinimix E Bags Due to Dried Skin Particulate Matter
FDA (Drugs) · 2016-06-01
- HighBaxter Recalls Clinimix E IV Bags Due to Sterility Concerns
FDA (Drugs) · 2014-12-24
- SevereBaxter Recalls Clinimix E IV Bags Due to Particulate Matter
FDA (Drugs) · 2014-03-26
- CriticalBaxter Recalls Clinimix E Bags Due to Particulate Matter
FDA (Drugs) · 2014-03-26
Same manufacturer · Baxter Healthcare Corp
See all →- HighBaxter Amia Automated Peritoneal Dialysis Set Recalled for Flow Issues
FDA (Devices) · 2017-09-20
- ModerateBaxter Recalls SIGMA Spectrum Infusion Pump Rear Case Assemblies
FDA (Devices) · 2016-12-07
- ModerateBaxter Recalls Sigma Spectrum Infusion Pumps Due to Speaker Failure Risk
FDA (Devices) · 2016-12-07
- ModerateBaxter SIGMA Spectrum Infusion Pump Recall for Speaker Failure
FDA (Devices) · 2016-12-07
- HighBaxter Recalls Revaclear MAX Dialyzers Due to Potential Particulate Matter
FDA (Devices) · 2016-11-16
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29